Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB01247_nanopub.RAdGahFv6HR4pPgdKY6mqrMDt_Iix_lbSpFpoVZyr29sg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB01247 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB01247 label "DDI between Zolmitriptan and Isocarboxazid - The MAO inhibitor, isocarboxazid, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing isocarboxazid are contraindicated. [drugbank_resource:DB00315_DB01247]" assertion.
- drugbank_resource:DB00315_DB01247 identifier "drugbank_resource:DB00315_DB01247" assertion.
- drugbank_resource:DB00315_DB01247 title "DDI between Zolmitriptan and Isocarboxazid - The MAO inhibitor, isocarboxazid, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing isocarboxazid are contraindicated." assertion.
- drugbank:DB01247 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB01247 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB01247 assertion.